脇坂尚宏

NAOHIRO WAKISAKA

競争的資金等の研究課題 (13件)：

2017 - 2021 上咽頭癌発癌ならびに多様性獲得分子機構の解析と新規治療法の開発
2016 - 2020 内因性免疫による頭頸部ウイルス発癌における内分泌撹乱物質の関与と新規治療法の開発
2015 - 2018 HPV陽性中咽頭癌におけるウイルス発癌機構へのAIDの関与
2014 - 2017 ヒト乳頭腫ウイルスシグナル伝達に着目した喉頭乳頭腫に対する新規治療の開発
2014 - 2017 代償性増殖による上咽頭癌発癌機構の解明と治療戦略

全件表示

論文 (112件)：

Naohiro Wakisaka, Makiko Moriyama-Kita, Satoru Kondo, Eiji Kobayashi, Takayoshi Ueno, Yosuke Nakanishi, Kazuhira Endo, Hisashi Sugimoto, Tomokazu Yoshizaki. Immune-Related Gene Expression Profile at Peritumoral Tonsillar Tissue Is Modified by Oropharyngeal Cancer Nodal Status. The American journal of pathology. 2023
Takahito Kondo, Kiyoaki Tsukahara, Daisuke Kawakita, Seiichi Yoshimoto, Kouki Miura, Masashi Sugasawa, Kazuaki Chikamatsu, Takashi Matsuzuka, Isao Oze, Morimasa Kitamura, et al. Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancer. International journal of clinical oncology. 2023. 28. 4. 512-520
Satoru Kondo, Atsushi Okabe, Takuya Nakagawa, Keisuke Matsusaka, Masaki Fukuyo, Bahityar Rahmutulla, Hirotomo Dochi, Harue Mizokami, Yuki Kitagawa, Tomoya Kurokawa, et al. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022. 166598-166598
Hirotomo Dochi, Satoru Kondo, Takayuki Murata, Masaki Fukuyo, Asuka Nanbo, Kousho Wakae, Wen-Ping Jiang, Toshihide Hamabe-Horiike, Mariko Tanaka, Takumi Nishiuchi, et al. Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma. Cancer science. 2022. 113. 8. 2862-2877
Satoru Kondo, Yusuke Okuno, Takayuki Murata, Hirotomo Dochi, Naohiro Wakisaka, Harue Mizokami, Makiko Moriyama-Kita, Eiji Kobayashi, Makoto Kano, Takeshi Komori, et al. EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non-endemic region. Cancer science. 2022. 113. 7. 2446-2456

MISC (150件)：

講演・口頭発表等 (9件)：

Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced- RADPLAT in advanced laryngeal cancer
(14th Korea Japan Joint Meeting of Otorhinolaryngology-Head and Neck Surgery 2012)
どのように治療法を使い分けてゆくか. 化学放射線療法(動注化学療法)
(第24回日本喉頭科学会 2012)
Regulation of cis-presentation of CD8+ T-cell epitopes by EBV-encoded LMP1 through self-aggregation
(14th International Symposiumu on EBV 2010)
Induction of receptor for advanced glycation end products by EpsteinBarr virus latent membrane protein 1 in nasopharyngeal carcinoma.
(The12th Japan-Korea Joint Meeting of Otorhinolaryngology-Head and Neck Surgery 2008)
EBV LMP1induces and causes release of fibroblast Growth factor-2.
(The10th Japan-Korea Joint Meeting of Otorhinolaryngology-Head and Neck Surgery 2004)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

脇坂 尚宏

脇坂尚宏